HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoo Hong Min Selected Research

Vincristine (Oncovin)

2/2014Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
1/2014High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoo Hong Min Research Topics

Disease

25Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 12/2003
17Leukemia
10/2020 - 10/2003
13Neoplasms (Cancer)
05/2020 - 04/2002
11Lymphoma (Lymphomas)
09/2020 - 04/2002
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2015 - 12/2008
6Multiple Myeloma
01/2022 - 04/2009
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2020 - 08/2012
4Hematologic Neoplasms (Hematological Malignancy)
09/2017 - 01/2014
4Bronchiolitis Obliterans Syndrome
12/2015 - 06/2004
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2022 - 08/2011
3Infections
10/2019 - 11/2010
3Hepatitis
10/2018 - 06/2004
3Fever (Fevers)
01/2014 - 01/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2012 - 10/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2020 - 09/2011
2Lymphopenia (Lymphocytopenia)
04/2016 - 08/2011
2Spinal Cord Injuries (Spinal Cord Injury)
01/2016 - 01/2009
2Thrombocytopenia (Thrombopenia)
06/2014 - 07/2012
2Iron Overload
06/2014 - 01/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2014 - 02/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013 - 09/2011
2Acute Promyelocytic Leukemia
08/2012 - 12/2008
2Chromosome Aberrations (Chromosome Abnormalities)
12/2010 - 12/2008
2Pathologic Complete Response
04/2009 - 04/2009
2Myeloid Sarcoma (Chloroma)
09/2007 - 04/2004
1Critical Illness (Critically Ill)
04/2021
1Hepatitis B
10/2018
1Immunoglobulin Light-chain Amyloidosis
01/2017
1Chromosomal Instability (Chromosome Stability)
01/2017
1Liver Neoplasms (Liver Cancer)
01/2017
1Bacterial Infections (Bacterial Infection)
04/2016
1Epstein-Barr Virus Infections
02/2016
1Carcinogenesis
02/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2015

Drug/Important Bio-Agent (IBA)

6RNA (Ribonucleic Acid)IBA
01/2021 - 04/2002
6Cytarabine (Cytosar-U)FDA LinkGeneric
11/2019 - 11/2010
5Biological ProductsIBA
02/2016 - 02/2007
4Ferritins (Ferritin)IBA
01/2016 - 01/2008
3Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2014
3Core Binding Factors (Core-Binding Factor)IBA
11/2020 - 06/2010
3DecitabineFDA Link
01/2017 - 10/2011
3Aurora Kinase AIBA
12/2016 - 11/2010
3Proteins (Proteins, Gene)FDA Link
02/2016 - 08/2004
3Azacitidine (5 Azacytidine)FDA Link
01/2015 - 01/2010
3Pharmaceutical PreparationsIBA
01/2014 - 10/2003
3Itraconazole (Sporanox)FDA LinkGeneric
01/2014 - 01/2014
3Rituximab (Mabthera)FDA Link
08/2012 - 04/2009
3Peroxidase (Myeloperoxidase)IBA
05/2012 - 09/2007
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2017
2Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2020 - 12/2008
2Phosphotransferases (Kinase)IBA
05/2020 - 01/2017
2C-Reactive ProteinIBA
05/2020 - 11/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2018 - 02/2007
2LigandsIBA
10/2017 - 09/2011
2Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 02/2014
2IronIBA
06/2014 - 01/2008
2Vincristine (Oncovin)FDA LinkGeneric
02/2014 - 01/2014
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2014 - 09/2012
2Transcription Factors (Transcription Factor)IBA
08/2012 - 12/2003
2Imatinib Mesylate (Gleevec)FDA Link
06/2012 - 06/2011
2Small Interfering RNA (siRNA)IBA
11/2010 - 11/2010
2CaspasesIBA
11/2010 - 10/2003
2Histone Deacetylase InhibitorsIBA
01/2004 - 10/2003
2apicidinIBA
01/2004 - 10/2003
1daratumumabIBA
01/2021
1HLA-DR Antigens (HLA-DR)IBA
10/2020
1enasidenibIBA
09/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2020
1Serum AlbuminIBA
05/2020
1Histone MethyltransferasesIBA
04/2020
1Amiloride (Midamor)FDA LinkGeneric
11/2019
1Sodium-Hydrogen Exchanger 1IBA
11/2019
1phorbolIBA
11/2019
1DNA (Deoxyribonucleic Acid)IBA
11/2017
1(+)-JQ1 compoundIBA
06/2017
1A-Form DNA (A-DNA)IBA
01/2017
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2017
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2016
1Bortezomib (Velcade)FDA Link
04/2016
1Histones (Histone)IBA
02/2016
1Polycomb Repressive Complex 2IBA
02/2016
1Protein Subunits (Protein Subunit)IBA
02/2016
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2016
1Busulfan (Busulfex)FDA Link
01/2016
1CytokinesIBA
12/2015
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
07/2015
1AlbuminsIBA
11/2014
1Hemoglobins (Hemoglobin)IBA
06/2014

Therapy/Procedure

16Hematopoietic Stem Cell Transplantation
04/2021 - 04/2004
15Therapeutics
01/2021 - 12/2008
13Stem Cell Transplantation
10/2019 - 02/2005
12Drug Therapy (Chemotherapy)
10/2018 - 02/2007
4Transplantation
01/2016 - 01/2008
1Organ Transplantation
04/2021
1Remission Induction
01/2021
1Salvage Therapy
04/2017
1Induction Chemotherapy
01/2016
1VAP-cyclo protocol
11/2014
1Consolidation Chemotherapy
08/2014